- Home
- ANVS vs MVIS Comparison
ANVS vs MVIS Comparison
Compare ANVS & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | MVIS |
|---|---|---|
| Founded | 2008 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.6M | 86.6M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ANVS | MVIS |
|---|---|---|
| Price | $1.20 | $1.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $13.50 | $2.25 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.39 | 23.91 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $664,000.00 |
| Revenue This Year | N/A | $529.06 |
| Revenue Next Year | N/A | $168.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.04 | $0.23 |
| 52 Week High | $5.50 | $4.90 |
Technical Indicators
Market Signals| Indicator | ANVS | MVIS |
|---|---|---|
| Relative Strength Index (RSI) | 32.63 | 49.49 |
| Support Level | N/A | $1.65 |
| Resistance Level | $2.02 | $1.93 |
| Average True Range (ATR) | 0.10 | 0.13 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 21.56 | 69.53 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.